Search by Drug Name, NDC or Jcode
Internal Navigation
HCPCS Details
HCPC | J9027 |
Short Description | Clofarabine injection |
Long Description | Injection, clofarabine, 1 mg |
Pricing indicator | 51 |
Coverage code | C |
ASC payment group code | YY |
BETOS2 code | O1E |
Action code | N |
Type of service | 1 |
Effective date | 2006-01-01 |
Date Added | 2006-01-01 |
HCPCS/NDC Cross-Walk
NDC | HCPC | Description | Drug Name | Labeler Name | HCPCS Dosage | PKG Size | PKG QTY | Bill Units | Bill Units PKG |
---|---|---|---|---|---|---|---|---|---|
00024586001 | J9027 | Clofarabine injection | Clolar | SANOFI-AVENTIS | 1 MG | 20 | 1 | 20 | 20 |
00955174601 | J9027 | Clofarabine injection | Clofarabine | SANOFI-AVENTIS | 1 MG | 20 | 1 | 20 | 20 |
43598030920 | J9027 | Clofarabine injection | CLOFARABINE | DR. REDDY'S LABORATORIES, INC. | 1 MG | 20 | 1 | 20 | 20 |
60505616600 | J9027 | Clofarabine injection | Clofarabine | APOTEX CORP. | 1 MG | 20 | 1 | 20 | 20 |
63323057270 | J9027 | Clofarabine injection | Clofarabine | FRESENIUS KABI | 1 MG | 20 | 1 | 20 | 20 |
67457054620 | J9027 | Clofarabine injection | CLOFARABINE | MYLAN INSTITUTIONAL LLC | 1 MG | 20 | 1 | 20 | 20 |
70121123601 | J9027 | Clofarabine injection | CLOFARABINE | AMNEAL BIOSCIENCES | 1 MG | 20 | 1 | 20 | 20 |
71288012820 | J9027 | Clofarabine injection | Clofarabine | Meitheal Pharmaceuticals, Inc. | 1 MG | 20 | 1 | 20 | 20 |
72266010801 | J9027 | Clofarabine injection | Clofarabine | FOSUN PHARMA | 1 MG | 20 | 1 | 20 | 20 |
HCPCS Billing Calculator
Dosage given to patient (per dose) | |
---|---|
HCPCS Dosage | 1 MG |
HCPCS/CPT Billing Units | 1 |
Total doses ordered | |
Billing Units | 1 |
Drug Details
-
Clofarabine is used to treat acute lymphoblastic leukemia (ALL; a type of cancer of the white blood cells) in children and young adults 1 to 21 years old who have already received at least two other treatments. Clofarabine is in a class of medications called purine nucleoside antimetabolites. It works by killing existing cancer cells and limiting the development of new cancer cells.